BIO Comments on USDA-AMS National Bioengineered Food Disclosure Standard
July 3, 2018
BIO submitted comments to the U.S. Department of Agriculture Agricultural Marketing Service (USDA-AMS) on the proposed rule, National Bioengineered Food Disclosure Standard.
BIO says several states have passed laws requiring labeling of certain bioengineered food, setting up the potential for a patchwork of different, conflicting national, state, and local labeling requirements. Because the patchwork legislation could threaten the free movement of food throughout the United States and worsen the stigma of new biotechnology, Congress passed the National Bioengineered Food Disclosure Law, which establishes a mandatory bioengineered food disclosure program with uniform national standards.
BIO says the disclosure program has not changed the Food & Drug Administration's (FDA) separate and distinct authority to require accurate labeling on all food, including bioengineered food, with respect to safety, nutrition, or material differences related to composition or certain properties of the food. BIO supports labeling laws and regulations as currently administered by the FDA and the principles underlying the USDA-AMS program establishing a uniform national bioengineered food disclosure standard.
In the comments, BIO makes recommendations to clarify disclosure requirements and terminology.
The Biotechnology Innovation Organization appreciates the opportunity to comment on the Center for Medicare and Medicaid Services’ Information Collection Request on the Part C and Part D Medicare Prescription Payment Plan Model Documents.
In response to their advance notice of proposed rulemaking (ANPRM), BIO submitted comments to the DOJ's National Security Division on implementing the White House Executive Order of February 28, 2024, “Preventing Access to Americans’ Bulk Sensitive…
We, the undersigned, are writing to express our strong concern with a proposed update to the Medicaid Drug Rebate Program. If finalized in its current form, the proposed rule (CMS-2434-P) would impose significant costs to the government and industry…
BIO submitted comments to the U.S. Department of Agriculture Agricultural Marketing Service (USDA-AMS) on the proposed rule, National Bioengineered Food Disclosure Standard.
BIO says several states have passed laws requiring labeling of certain bioengineered food, setting up the potential for a patchwork of different, conflicting national, state, and local labeling requirements. Because the patchwork legislation could threaten the free movement of food throughout the United States and worsen the stigma of new biotechnology, Congress passed the National Bioengineered Food Disclosure Law, which establishes a mandatory bioengineered food disclosure program with uniform national standards.
BIO says the disclosure program has not changed the Food & Drug Administration's (FDA) separate and distinct authority to require accurate labeling on all food, including bioengineered food, with respect to safety, nutrition, or material differences related to composition or certain properties of the food. BIO supports labeling laws and regulations as currently administered by the FDA and the principles underlying the USDA-AMS program establishing a uniform national bioengineered food disclosure standard.
In the comments, BIO makes recommendations to clarify disclosure requirements and terminology.